# Silexan in the Treatment Of Posttraumatic Stress Disorder Trial

> **NCT06412757** · PHASE3 · RECRUITING · sponsor: **Deakin University** · enrollment: 278 (estimated)

## Conditions studied

- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** Silexan
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06412757
- **Lead sponsor:** Deakin University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-26
- **Primary completion:** 2027-05
- **Final completion:** 2027-06
- **Target enrollment:** 278 (ESTIMATED)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06412757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06412757, "Silexan in the Treatment Of Posttraumatic Stress Disorder Trial". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06412757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*